top of page
Screen Shot Data mgmt.png

Global Mental Health Summit and Workshops

 

Global Psychedelics Therapist Alliance and Global Ibogaine Therapist Alliance

Working Group

Become a facilitators and mental health professionals Join and Signup for the NYS in Action for the Ibogaine Clinical Research Act

​

Licensed, credentialed, trained Nurses, Integrative medical Professional can conduct medical screening for  treatment recommendations.   Join the workshop!

 

Global Psychedelics Therapist Alliance and Global Ibogaine Therapist Alliance.

 

Join the NYS Global Ibogaine Therapist Alliance

 

          * Request a copy of Ibogaine Therapist Treatment Manual (Download)

 

Join the Scientific consortium for ibogaine & psychedelic medical research Workshop 

 

           * Request a copy of Freedom to Operate Declaration (Download)

 

Join the Consortium as NGO and Civil Society Action Group

 

Become a Private Public Sector Partner of Consortium for Ibogaine Clinical Research

 

Join the Access for Benefit Sharing of Ibogaine IP protection

 

 

Background and History of Ibogaine

 

Ibogaine has demonstrated promise for Opioid and substance use disorders (SUDs), psychotherapy, and personal spiritual growth. NYC as a birth of Manhattan Project, since 1986, Howard Lotsof’s patent initiation for OUD/SUD/AUD/ and others, many ibogaine treatments are conducted “underground” subcultures in unregulated regions and may after 45 years of NYS legislation for Ibogaine, KRFI is entering into a FDA Investigative New Drug with treatments for poly opioid protocols to ensure the safety of the participant. This study arose to fill the Poly drug opioid endemic and bring evidence base collective data on the potential of ibogaine as a treatment option with the global scientific communities and for health equity and mental health treatment policy.

bottom of page